Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than ...

The new plan allows plaintiffs who sued Purdue to opt in to receive their settlement or reserve their right to file a civil suit against the billionaire Sackler family.

About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.

FILE PHOTO: Bottles of prescription painkiller OxyContin made by Purdue Pharma LP sit on a shelf at a local pharmacy in Provo ...

Please send tips or suggestions to D.Thomas@thomsonreuters.com, opens new tab) Purdue Pharma's bankruptcy entered a new, possibly final phase this week when the drugmaker filed a new $7.4 billion ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

Purdue Pharma Files New Bankruptcy Plan for $7.4 Billion Opioid Settlement By Dietrich Knauth NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday ...

Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback in the U.S. Supreme Court ...